Biographies

 

 

 

 

December 14, 2006 Presentation: Novel Diagnostic Markers of Early Acute Kidney Injury

Image of Dr. Prasad Devarajan

Dr. Prasad Devarajan is the Louise M. Williams Endowed Chair and professor of pediatrics and developmental biology at the Cincinnati Children’s Hospital Medical Center. He is also director of nephrology and hypertension.

 

In 2005, Dr. Devarajan was recognized as one of the “2005 Best Doctors.” He serves as a reviewer for The Lancet, Journal of Cell Biology, Journal of Biological Chemistry, Frontiers in Bioscience, Quarterly Reviews in Biology, American Journal of Physiology, Journal of American Society of Nephrology, Pediatric Nephrology, Kidney International, Laboratory Investigation, Journal of Urology and Journal of Hormone and Metabolic Research. In addition, he is an abstract reviewer for the American Society of Nephrology and Society for Pediatric Research as well as an external and ad hoc reviewer for the National Institutes of Health (NIH) and National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK).

 

Currently, Dr. Devarajan is a member of the Council on Kidney in Cardiovascular Disease, American Society for Pediatric Nephrology Scientific Council and Eastern Society for Pediatric Research. Dr. Devarajan received both his premedical and M.D. degrees from Bombay University in India. He completed his graduate research, an internship and residency at State University of New York. Dr. Devarajan was a NIH Fellow, received a Postdoctoral Fellowship and served as a research assistant at Yale University School of Medicine. Later he taught as an assistant professor in Yale’s Department of Pediatrics.

 

Dr. Devarajan continued his teaching career at Albert Einstein College of Medicine’s Department of Pediatrics. He served as the director of research while earning the title of associate professor. In July 2002, Dr. Devarajan began his current position as the Williams Professor of Pediatrics and Developmental Biology and director of nephrology and hypertension at Cincinnati Children's Hospital Medical Center.

 

Dr. Devarajan has served as principal investigator on several NIH and NIDDK studies. Over the past two years, he served as the principal investigator for the American Heart Association’s study on “A novel biomarker for early ischemic renal injury.”

 

Dr. Devarajan’s recent publications include “Neutrophil Gelatinase-Associated Lipocalin (NGAL): A novel urinary biomarker for cisplatin nephrotoxicity” in the American Journal of Nephrology, “Amelioration of ischemic acute renal injury by NGAL” in the Journal of the American Society of Nephrology and “Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury following cardiac surgery” in The Lancet.

Image of Dr. Robert H. Christenson

Robert Christenson, PhD, DABCC, FACB, is Professor of Pathology and Professor of Medical and Research Technology at the University of Maryland School of Medicine, Baltimore, Maryland. Clinically, Dr. Christenson is Director of the Clinical Chemistry, Toxicology & Rapid Response Laboratories at the University of Maryland Medical Center, where he is also Director of Informatics and Point of Care Services.

 

Dr. Christenson graduated magna cum laude from the University of Massachusetts in 1976 with a BS in Chemistry. He received his PhD in Analytical Chemistry from Florida State University in 1980 and completed post-doctoral training in clinical chemistry at the University of North Carolina, Chapel Hill. Dr. Christenson subsequently joined the faculty of Duke University in 1982 as an Assistant Professor of Pathology and was Chief of Clinical Chemistry, Special Chemistry and Informatics at the Durham VA Medical Center until 1991 when he joined the faculty at Maryland. Dr. Christenson was certified as a diplomat of the American Board of Clinical Chemistry in 1984 and is a Fellow of the National Academy of Clinical Biochemists.

 

Dr. Christenson has published 95 peer-reviewed manuscripts, over 110 abstracts, and 35 book chapters and monographs. He has served as a member of the Board of Editors for the journals Clinical Biochemistry, Clinical Chemistry, and the Journal of Clinical and Laboratory Analysis.

 

Dr. Christenson’s educational activities include organizing and teaching numerous courses and lectures to medical and graduate students. He has served as mentor to numerous graduate and undergraduate students and directs the University of Marlyand’s ComACC certified postdoctoral training program

Page Access: